Nonalcoholic Fatty Liver Disease -- New Insight Into a Major Cause of (Hep C)

Nonalcoholic Fatty Liver Disease -- New Insight Into a Major Cause of
Medscape News - Research presented during this year's meeting of the American Association for the Study of Liver Diseases (AASLD) addressed important advances in our understanding of the hepatic consequences of obesity -- nonalcoholic fatty liver disease (NAFLD), a

FDA gives Fast Track status to Vertex s Hepatitis C treatment
Mass High Tech - The U.S. Food and Drug Administration has granted Fast Track designation to VX-950, an investigational oral hepatitis C virus (HCV) treatment being developed by Vertex Pharmaceuticals Inc. According to Vertex officials, the FDA granted the Fast Track